Literature DB >> 15853916

Effect of LACK and KMP11 on IFN-gamma production by peripheral blood mononuclear cells from cutaneous and mucosal leishmaniasis patients.

L P Carvalho1, S Passos, W O Dutra, M Soto, C Alonso, K J Gollob, E M Carvalho, A Ribeiro de Jesus.   

Abstract

The immune modulatory properties of recombinant antigens Kinetoplasmid membrane protein-11 (KMP11) and Leishmania homologue of receptors for activated C kinase (LACK) in cutaneous leishmaniasis (CL) and mucosal leishmaniasis (ML) patients were evaluated. The mean levels of interferon-gamma (IFN-gamma) in soluble leishmania antigen (SLA) stimulated peripheral blood mononuclear cells (PBMC) of ML and CL patients were 5625 +/- 2333 pg/ml and 4422 +/- 3665 pg/ml, respectively. IFN-gamma was not detected in cultures stimulated with KMP11 or LACK. Interleukin-10 (IL-10) concentration in SLA, KMP11 and LACK-stimulated PBMC of ML patients was 13 +/- 12 pg/ml, 285 +/- 388 pg/ml and 802 +/- 483 pg/ml, respectively. Addition of KMP11 or LACK to SLA-stimulated PBMC of CL and ML patients enhanced IL-10 production (P < 0.05). Addition of KMP11 decreased IFN-gamma levels by 52% in CL patients and by 19% in ML patients. Addition of LACK to SLA-stimulated cultures decreased IFN-gamma levels by 58% in CL patients and by 30% in ML patients. Neutralization of IL-10 abrogated the downregulatory effect of LACK and KMP11. The modulatory properties of LACK and KMP11 are due to induction of IL-10 production and may be helpful for attenuating chronic inflammatory diseases. However, in some clinical conditions, as demonstrated for ML, these molecules are not able to suppress the IFN-gamma response, even inducing IL-10 production.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15853916     DOI: 10.1111/j.1365-3083.2005.01581.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  21 in total

Review 1.  The genetics of Leishmania virulence.

Authors:  Eugenia Bifeld; Joachim Clos
Journal:  Med Microbiol Immunol       Date:  2015-06-06       Impact factor: 3.402

2.  Humoral and in vivo cellular immunity against the raw insect-derived recombinant Leishmania infantum antigens KMPII, TRYP, LACK, and papLe22 in dogs from an endemic area.

Authors:  Felicitat Todolí; Laia Solano-Gallego; Rafael de Juan; Pere Morell; Maria Del Carmen Núñez; Rodrigo Lasa; Silvia Gómez-Sebastián; José M Escribano; Jordi Alberola; Alhelí Rodríguez-Cortés
Journal:  Am J Trop Med Hyg       Date:  2010-12       Impact factor: 2.345

3.  Interleukin-4 (IL-4) and IL-10 collude in vaccine failure for novel exacerbatory antigens in murine Leishmania major infection.

Authors:  Mark T M Roberts; Carmel B Stober; Andrew N McKenzie; Jenefer M Blackwell
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

4.  Contrasting human cytokine responses to promastigote whole-cell extract and the Leishmania analogue receptor for activated C kinase antigen of L. amazonensis in natural infection versus immunization.

Authors:  R B G Azeredo-Coutinho; D C S Matos; G G R Armôa; R M Maia; A Schubach; W Mayrink; S C F Mendonça
Journal:  Clin Exp Immunol       Date:  2008-07-08       Impact factor: 4.330

5.  Proteinases as virulence factors in Leishmania spp. infection in mammals.

Authors:  Mariana Silva-Almeida; Bernardo Acácio Santini Pereira; Michelle Lopes Ribeiro-Guimarães; Carlos Roberto Alves
Journal:  Parasit Vectors       Date:  2012-08-07       Impact factor: 3.876

6.  Head-to-head comparison of three vaccination strategies based on DNA and raw insect-derived recombinant proteins against Leishmania.

Authors:  Felicitat Todolí; Alhelí Rodríguez-Cortés; María Del Carmen Núñez; Márcia D Laurenti; Silvia Gómez-Sebastián; Fernando Rodríguez; Eva Pérez-Martín; José M Escribano; Jordi Alberola
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

7.  Towards development of novel immunization strategies against leishmaniasis using PLGA nanoparticles loaded with kinetoplastid membrane protein-11.

Authors:  Diego M Santos; Marcia W Carneiro; Tatiana R de Moura; Kiyoshi Fukutani; Jorge Clarencio; Manuel Soto; Socorro Espuelas; Claudia Brodskyn; Aldina Barral; Manoel Barral-Netto; Camila I de Oliveira
Journal:  Int J Nanomedicine       Date:  2012-04-24

Review 8.  Leishmania exosomes deliver preemptive strikes to create an environment permissive for early infection.

Authors:  Judith Maxwell Silverman; Neil E Reiner
Journal:  Front Cell Infect Microbiol       Date:  2012-01-09       Impact factor: 5.293

9.  Proteomic analysis of the secretome of Leishmania donovani.

Authors:  J Maxwell Silverman; Simon K Chan; Dale P Robinson; Dennis M Dwyer; Devki Nandan; Leonard J Foster; Neil E Reiner
Journal:  Genome Biol       Date:  2008-02-18       Impact factor: 13.583

10.  Interleukin-10-dependent down-regulation of interferon-gamma response to Leishmania by Mycobacterium leprae antigens during the clinical course of a coinfection.

Authors:  R B G Azeredo-Coutinho; D C S Matos; J A C Nery; C M Valete-Rosalino; S C F Mendonça
Journal:  Braz J Med Biol Res       Date:  2012-05-10       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.